| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUMATRIPTAN SUCCINATE | 219036 | 002 | ANDA | SUMATRIPTAN SUCCINATE | TABLET;ORAL | EQ 50MG BASE | No | No | 2024/12/31 | 2024/12/31 | VKT PHARMA | Prescription |
| SUMATRIPTAN SUCCINATE | 219036 | 003 | ANDA | SUMATRIPTAN SUCCINATE | TABLET;ORAL | EQ 100MG BASE | No | No | 2024/12/31 | 2024/12/31 | VKT PHARMA | Prescription |
| SUMATRIPTAN SUCCINATE | 206019 | 001 | ANDA | SUMATRIPTAN SUCCINATE | TABLET;ORAL | EQ 25MG BASE | No | No | 2025/07/15 | 2025/07/15 | IPCA LABS LTD | Prescription |
| SUMATRIPTAN SUCCINATE | 206019 | 002 | ANDA | SUMATRIPTAN SUCCINATE | TABLET;ORAL | EQ 50MG BASE | No | No | 2025/07/15 | 2025/07/15 | IPCA LABS LTD | Prescription |
| SUMATRIPTAN SUCCINATE | 206019 | 003 | ANDA | SUMATRIPTAN SUCCINATE | TABLET;ORAL | EQ 100MG BASE | No | No | 2025/07/15 | 2025/07/15 | IPCA LABS LTD | Prescription |
| SUMATRIPTAN SUCCINATE | 213518 | 001 | ANDA | SUMATRIPTAN SUCCINATE | INJECTABLE;SUBCUTANEOUS | EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) | No | No | 2025/11/06 | 2025/11/06 | ALEMBIC | Prescription |
| SUMATRIPTAN SUCCINATE | 213518 | 002 | ANDA | SUMATRIPTAN SUCCINATE | INJECTABLE;SUBCUTANEOUS | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | No | No | 2025/11/06 | 2025/11/06 | ALEMBIC | Prescription |